Chemours Company (The) Analysis
| Analyst Ratings |
|
Average Target Price
|
35.17
|
|
Average Rating
|
3.23
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
9
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
1.04
|
1.24
|
0.20
|
19.23%
|
|
2022-06-30
|
1.44
|
1.89
|
0.45
|
31.25%
|
|
2022-03-31
|
0.92
|
1.46
|
0.54
|
58.70%
|
|
2021-12-31
|
0.92
|
0.81
|
-0.11
|
-11.96%
|
|
2021-09-30
|
1.02
|
1.27
|
0.25
|
24.51%
|
|
2021-06-30
|
0.95
|
1.20
|
0.25
|
26.32%
|
|
2021-03-31
|
0.63
|
0.71
|
0.08
|
12.70%
|
|
2020-12-31
|
0.41
|
0.61
|
0.20
|
48.78%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
4.59
|
|
2021-12-31
|
3.99
|
|
2020-12-31
|
1.97
|
|
2019-12-31
|
2.50
|
|
2018-12-31
|
5.66
|
|
2017-12-31
|
3.93
|
|
2016-12-31
|
1.29
|
|
2015-12-31
|
0.59
|